# OnCo record paper-flot4-lancet-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-flot4-lancet-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-flot4-lancet-2019" ;
  schema:name "FLOT4-AIO: perioperative FLOT versus ECF/ECX for resectable gastric or gastro-oesophageal junction adenocarcinoma"@en ;
  schema:description "Perioperative chemotherapy with docetaxel, oxaliplatin, fluorouracil and leucovorin (FLOT) lengthened survival compared with the older anthracycline-based regimen in operable stomach and junctional cancers, making FLOT the standard in Europe."@en ;
  schema:url <https://onco.cc/key-papers/paper-flot4-lancet-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(18)32557-1>, <https://pubmed.ncbi.nlm.nih.gov/30982686/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(18)32557-1> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Al-Batran SE, Homann N, Pauligk C, et al." ;
  onco:cancers <https://onco.cc/cancers/oesophageal-adenocarcinoma/>, <https://onco.cc/cancers/gastric-pdl1-high/>, <https://onco.cc/cancers/gastric-her2-positive/> ;
  onco:drugs <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/epirubicin/>, <https://onco.cc/drugs/oxaliplatin/> ;
  onco:trials <https://onco.cc/trials/flot4/> ;
  onco:journals <https://onco.cc/journals/lancet/> .